118 related articles for article (PubMed ID: 15056460)
21. Anti-Yo positive paraneoplastic cerebellar degeneration associated with ovarian carcinoma: case report and review of the literature.
Cao Y; Abbas J; Wu X; Dooley J; van Amburg AL
Gynecol Oncol; 1999 Oct; 75(1):178-83. PubMed ID: 10502450
[TBL] [Abstract][Full Text] [Related]
22. BRD7, a novel bromodomain gene, inhibits G1-S progression by transcriptionally regulating some important molecules involved in ras/MEK/ERK and Rb/E2F pathways.
Zhou J; Ma J; Zhang BC; Li XL; Shen SR; Zhu SG; Xiong W; Liu HY; Huang H; Zhou M; Li GY
J Cell Physiol; 2004 Jul; 200(1):89-98. PubMed ID: 15137061
[TBL] [Abstract][Full Text] [Related]
23. Trial to establish an animal model of paraneoplastic cerebellar degeneration with anti-Yo antibody. 1. Mouse strains bearing different MHC molecules produce antibodies on immunization with recombinant Yo protein, but do not cause Purkinje cell loss.
Tanaka M; Tanaka K; Onodera O; Tsuji S
Clin Neurol Neurosurg; 1995 Feb; 97(1):95-100. PubMed ID: 7788981
[TBL] [Abstract][Full Text] [Related]
24. The MAZ protein is an autoantigen of Hodgkin's disease and paraneoplastic cerebellar dysfunction.
Bataller L; Wade DF; Graus F; Rosenfeld MR; Dalmau J
Ann Neurol; 2003 Jan; 53(1):123-7. PubMed ID: 12509857
[TBL] [Abstract][Full Text] [Related]
25. Induction of anti-Purkinje cell antibodies in vivo by immunizing with a recombinant 52-kDa paraneoplastic cerebellar degeneration-associated protein.
Sakai K; Gofuku M; Kitagawa Y; Ogasawara T; Hirose G
J Neuroimmunol; 1995 Jul; 60(1-2):135-41. PubMed ID: 7642741
[TBL] [Abstract][Full Text] [Related]
26. An interferon-gamma ELISPOT and immunohistochemical investigation of cytotoxic T lymphocyte-mediated tumour immunity in patients with paraneoplastic cerebellar degeneration and anti-Yo antibodies.
Sutton IJ; Steele J; Savage CO; Winer JB; Young LS
J Neuroimmunol; 2004 May; 150(1-2):98-106. PubMed ID: 15081253
[TBL] [Abstract][Full Text] [Related]
27. Cytotoxic T cells against a peptide of Yo protein in patients with paraneoplastic cerebellar degeneration and anti-Yo antibody.
Tanaka M; Tanaka K; Tokiguchi S; Shinozawa K; Tsuji S
J Neurol Sci; 1999 Sep; 168(1):28-31. PubMed ID: 10500270
[TBL] [Abstract][Full Text] [Related]
28. Disruption of Rb/E2F pathway results in increased cyclooxygenase-2 expression and activity in prostate epithelial cells.
Davis JN; McCabe MT; Hayward SW; Park JM; Day ML
Cancer Res; 2005 May; 65(9):3633-42. PubMed ID: 15867358
[TBL] [Abstract][Full Text] [Related]
29. FLASH acts as a co-activator of the transcription factor c-Myb and localizes to active RNA polymerase II foci.
Alm-Kristiansen AH; Saether T; Matre V; Gilfillan S; Dahle O; Gabrielsen OS
Oncogene; 2008 Aug; 27(34):4644-56. PubMed ID: 18408764
[TBL] [Abstract][Full Text] [Related]
30. Inflammatory infiltrates and complete absence of Purkinje cells in anti-Yo-associated paraneoplastic cerebellar degeneration.
Verschuuren J; Chuang L; Rosenblum MK; Lieberman F; Pryor A; Posner JB; Dalmau J
Acta Neuropathol; 1996; 91(5):519-25. PubMed ID: 8740233
[TBL] [Abstract][Full Text] [Related]
31. HLA antigens in paraneoplastic cerebellar degeneration associated with anti-Yo antibody.
Tanaka M; Tanaka K; Tsuji S
Neurodegeneration; 1994 Dec; 3(4):341-2. PubMed ID: 7842305
[No Abstract] [Full Text] [Related]
32. c-Myb protein interacts with Rcd-1, a component of the CCR4 transcription mediator complex.
Haas M; Siegert M; Schürmann A; Sodeik B; Wolfes H
Biochemistry; 2004 Jun; 43(25):8152-9. PubMed ID: 15209511
[TBL] [Abstract][Full Text] [Related]
33. PP2A-dependent transactivation of the cyclin A promoter by SV40 ST is mediated by a cell cycle-regulated E2F site.
Skoczylas C; Henglein B; Rundell K
Virology; 2005 Feb; 332(2):596-601. PubMed ID: 15680424
[TBL] [Abstract][Full Text] [Related]
34. Interaction of E2F-Rb family members with corepressors binding to the adjacent E2F site.
Nakajima Y; Yamada S; Kamata N; Ikeda MA
Biochem Biophys Res Commun; 2007 Dec; 364(4):1050-5. PubMed ID: 17976373
[TBL] [Abstract][Full Text] [Related]
35. E2F sites in the Op18 promoter are required for high level of expression in the human prostate carcinoma cell line PC-3-M.
Polzin RG; Benlhabib H; Trepel J; Herrera JE
Gene; 2004 Oct; 341():209-18. PubMed ID: 15474303
[TBL] [Abstract][Full Text] [Related]
36. Paraneoplastic cerebellar degeneration: Yo antibody alters mitochondrial calcium buffering capacity.
Panja D; Vedeler CA; Schubert M
Neuropathol Appl Neurobiol; 2019 Feb; 45(2):141-156. PubMed ID: 29679372
[TBL] [Abstract][Full Text] [Related]
37. [Immunobiological approach to spinocerebellar degeneration--anti-Purkinje cell antibodies in paraneoplastic cerebellar degeneration].
Miyatake T
Rinsho Shinkeigaku; 1993 Dec; 33(12):1291-3. PubMed ID: 8174327
[TBL] [Abstract][Full Text] [Related]
38. The proximal promoter of the human cathepsin G gene conferring myeloid-specific expression includes C/EBP, c-myb and PU.1 binding sites.
Lennartsson A; Garwicz D; Lindmark A; Gullberg U
Gene; 2005 Aug; 356():193-202. PubMed ID: 16019164
[TBL] [Abstract][Full Text] [Related]
39. Transcriptional repression by the basic helix-loop-helix protein Dec2: multiple mechanisms through E-box elements.
Fujimoto K; Hamaguchi H; Hashiba T; Nakamura T; Kawamoto T; Sato F; Noshiro M; Bhawal UK; Suardita K; Kato Y
Int J Mol Med; 2007 Jun; 19(6):925-32. PubMed ID: 17487425
[TBL] [Abstract][Full Text] [Related]
40. Regulation of CAPRICE transcription by MYB proteins for root epidermis differentiation in Arabidopsis.
Koshino-Kimura Y; Wada T; Tachibana T; Tsugeki R; Ishiguro S; Okada K
Plant Cell Physiol; 2005 Jun; 46(6):817-26. PubMed ID: 15795220
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
